Get started Log in

IPN — Ipsen SA Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Market Cap
€13.07bn
Enterprise Value
€12.06bn
Revenue
€3.93bn

Brief: Ipsen Gains Global Rights For Development, Manufacturing Of SIM0613
22/12/2025 06:16
Ipsen shares fall after failed trial on experimental FOP drug
19/12/2025 08:39
Brief: Ipsen: Phase II Falkon Trial Did Not Meet Primary Endpoint
19/12/2025 06:04
Brief: Ipsen Completes Acquisition Of Imcheck Therapeutics
15/12/2025 16:30
Brief: Ipsen: Beech Tree Shares To Be Transferred To Alasol Foundation
05/12/2025 05:59
BNP Paribas Exane downgrades Ipsen to 'underperform' amid competitive pressures
26/11/2025 07:09
Europe Research Roundup: Adidas, Boliden, LSEG
24/10/2025 08:27
Brief: Eqt Life Sciences' Imcheck Therapeutics To Be Acquired By Ipsen
22/10/2025 08:27
Ipsen rises after Q3 beat, outlook hike
22/10/2025 08:27
Brief: Gimv Sells Imcheck Therapeutics Stake To Ipsen For EUR 350 Mln
22/10/2025 06:34
Brief: Ipsen To Acquire Imcheck Therapeutics
22/10/2025 06:07
Brief: Ipsen Q3 Revenue EUR 915 Million, Upgrades 2025 Outlook
22/10/2025 06:07
Europe Research Roundup: Kingfisher, Phoenix and Thule
24/09/2025 08:29
Brief: Ipsen Shares First Aesthetic Data For IPN10200 In Phase II Trial
22/09/2025 06:10
Brief: Bylvay (Odevixibat) Approved In Japan For Rare Liver Disease Pfic
19/09/2025 13:00
Brief: Ipsen Now Expects 2025 Sales Growth Above 7%
31/07/2025 06:42
Brief: Ipsen SA Says Cabometyx Approved In EU For Previously Treated Advanced Neuroendocrine Tumors
24/07/2025 19:25
Brief: Ipsen Initiates Share Buy-Back Program
02/06/2025 06:03
Brief: Ipsen SA Says Late-Breaking Analysis Demonstrates Characteristics Associated With Long-Term Overall Survival With Onivyde Regimen In Metastatic Pancreatic Adenocarcinoma
31/05/2025 13:13
Brief: Ipsen: Impact Of Iqirvo On Fatigue
07/05/2025 07:04